Abstract
Gold salts have been introduced as therapeutic agents in the late 19th century. The three gold salts approved for medical therapy auranofin, aurothiomalate, and aurothioglucose were shown to induce anti-inflammatory and immunosuppressive states via a myriad of mechanisms and used to be a mainstay of therapy for rheumatoid arthritis as well as other rheumatic and collagen vascular diseases before being supplanted by other less toxic agents. The research into the role of gold compounds in therapy of pulmonary disease have focused on asthma and demonstrated a significant anti-inflammatory effect as well as a mild steroid-sparing effect mainly in Japanese patients. These effects were offset by a wide array of adverse reactions, notably dermatological, hematological and renal effects. The main pulmonic adverse effect associated with gold therapy is interstitial pneumonitis which can present with an acute, subacute and chronic course. The role of gold salts in the therapeutic arsenal of COPD and interstitial lung diseases is less established. Recently published studies have investigated the role of aurothiomalate as an inhibitor of non-small cell lung cancer oncogene PKC iota.
Keywords: Adverse effects, asthma, gold, interstitial lung disease.
Current Respiratory Medicine Reviews
Title:Gold Salts Therapy in Respiratory Diseases
Volume: 9 Issue: 5
Author(s): Ori-Michael J. Benhamou, Maly N. Oron, Maor Waldman and Or Kalchiem-Dekel
Affiliation:
Keywords: Adverse effects, asthma, gold, interstitial lung disease.
Abstract: Gold salts have been introduced as therapeutic agents in the late 19th century. The three gold salts approved for medical therapy auranofin, aurothiomalate, and aurothioglucose were shown to induce anti-inflammatory and immunosuppressive states via a myriad of mechanisms and used to be a mainstay of therapy for rheumatoid arthritis as well as other rheumatic and collagen vascular diseases before being supplanted by other less toxic agents. The research into the role of gold compounds in therapy of pulmonary disease have focused on asthma and demonstrated a significant anti-inflammatory effect as well as a mild steroid-sparing effect mainly in Japanese patients. These effects were offset by a wide array of adverse reactions, notably dermatological, hematological and renal effects. The main pulmonic adverse effect associated with gold therapy is interstitial pneumonitis which can present with an acute, subacute and chronic course. The role of gold salts in the therapeutic arsenal of COPD and interstitial lung diseases is less established. Recently published studies have investigated the role of aurothiomalate as an inhibitor of non-small cell lung cancer oncogene PKC iota.
Export Options
About this article
Cite this article as:
Benhamou J. Ori-Michael, Oron N. Maly, Waldman Maor and Kalchiem-Dekel Or, Gold Salts Therapy in Respiratory Diseases, Current Respiratory Medicine Reviews 2013; 9 (5) . https://dx.doi.org/10.2174/1573398X10666140526234128
DOI https://dx.doi.org/10.2174/1573398X10666140526234128 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews Uric Acid and Diabetes: Is there a Link?
Current Pharmaceutical Design Recent Insights into the Role of Prostanoids in Atherosclerotic Vascular Disease
Current Vascular Pharmacology Adiposity and Alzheimers Disease
Current Alzheimer Research The Mineralocorticoid Receptor in Endothelial Physiology and Disease: Novel Concepts in the Understanding of Erectile Dysfunction
Current Pharmaceutical Design Heavy Metal Toxicity in Humans and its Preventive and Control Measures
Current Nutrition & Food Science NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive β-Cell Dysfunction and Metabolic Syndrome
Current Drug Targets Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation
Cardiovascular & Hematological Disorders-Drug Targets Combined Antiplatelet Therapy: Still a Sweeping Combination in Cardiology
Cardiovascular & Hematological Agents in Medicinal Chemistry The Concomitance of Hypertension and Diabetes Exacerbating Retinopathy: The Role of Inflammation and Oxidative Stress.
Current Clinical Pharmacology Matrix Metalloproteinases and Vulnerable Atheromatous Plaque
Current Topics in Medicinal Chemistry Fabrication and Applications of Nanoparticle-Modified Electrodes in Stripping Analysis
Current Analytical Chemistry Editorial (Thematic Issue: Endothelium: A Target for Therapeutic Intervention)
Current Vascular Pharmacology Follicular Cysts: A Single Sign and Different Diseases. A View from Comparative Medicine
Current Pharmaceutical Design Stroke in Women - Oral Contraception, Pregnancy, and Hormone Replacement Therapy
Current Vascular Pharmacology Cardiovascular Effects of Current and Future Anti-Obesity Drugs
Current Vascular Pharmacology Editorial: Ageing, Longevity, Exceptional Longevity and Related Genetic and Non Genetics Markers: Panel Statement
Current Vascular Pharmacology Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry Targeting Drugs to APJ Receptor: The Prospect of Treatment of Hypertension and Other Cardiovascular Diseases
Current Drug Targets Genistein: A Boon for Mitigating Ischemic Stroke
Current Topics in Medicinal Chemistry